IB

Indran Brar

Active Director Director DIN 00454081
DIN 00454081 First appointment Apr 1994 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Apr 1994
Shareholding value •••• Premium profile

About Indran Brar

Data last updated:

Indran Brar is a Director at Madhubani Investments Private Limited (since 1997), Director at Green Vally Land And Development Private Limited (since 1997) and Director at Suraj Overseas Private Limited (since 1997), and holds 3 more current directorships. The companies operate in Financial Services, Agriculture and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹10.32 Cr; the largest is Madhubani Investments Private Limited at ₹6.82 Cr (FY 2024). Earlier, Indran Brar was a Director at Chetak Pharmaceuticals Pvt Ltd (from 1999).

DIN 00454081
Primary Designation Director
Industry Financial Services
First Appointment 28 Apr 1994
Oldest Company Age 42 yrs
Largest company Madhubani Investments Private Limited · ₹6.82 Cr (FY 2024)
Combined revenue ₹10.32 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Dec 19971991₹6.82 Cr (FY 2024)Active
Director18 Dec 19971989₹2.74 Cr (FY 2024)Active
Suraj Overseas Private Limited U74899TG1991PTC151553
Director18 Dec 19971991₹59.7 Lakh (FY 2025)Active
Suraj Hotels Private Limited U74899TG1991PTC135659
Director28 Apr 19941991₹15.7 Lakh (FY 2025)Active
Director15 Oct 20072007Active
Director01 Mar 20042004Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chetak Pharmaceuticals Pvt Ltd U24232PB1984PTC005717
Director22 Nov 19991984Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chetak Pharmaceuticals Pvt Ltd
Davix Pharmaceuticals Private Limited
Davix Managaement Services Private Limited
Green Vally Land And Development Private Limited
Premium access

Shareholding and investment profile for Indran Brar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indran Brar

Indran Brar currently holds 6 directorships: Madhubani Investments Private Limited (Director, since 18 Dec 1997, revenue ₹6.82 Cr (FY 2024)); Green Vally Land And Development Private Limited (Director, since 18 Dec 1997, revenue ₹2.74 Cr (FY 2024)); Suraj Overseas Private Limited (Director, since 18 Dec 1997, revenue ₹59.7 Lakh (FY 2025)); Suraj Hotels Private Limited (Director, since 28 Apr 1994, revenue ₹15.7 Lakh (FY 2025)); Davix Pharmaceuticals Private Limited (Director, since 15 Oct 2007); and 1 more.

Indran Brar was first appointed on 28 Apr 1994 as Director at Suraj Hotels Private Limited. The most recent appointment on record is 15 Oct 2007 at Davix Pharmaceuticals Private Limited.

The 4 current companies of Indran Brar that report revenue have a combined latest revenue of ₹10.32 Cr: Madhubani Investments Private Limited ₹6.82 Cr (FY 2024); Green Vally Land And Development Private Limited ₹2.74 Cr (FY 2024); Suraj Overseas Private Limited ₹59.7 Lakh (FY 2025); Suraj Hotels Private Limited ₹15.7 Lakh (FY 2025).

Indran Brar held 1 earlier board appointment: Chetak Pharmaceuticals Pvt Ltd (Director, from 22 Nov 1999).

The current boards of Indran Brar's companies include Davinder Singh Brar (Madhubani Investments Private Limited), Anandbir Singh Brar (Davix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available